Long term survival in adult osteosarcoma patients treated with a two-drug regimen: Final results of the OSAD93 phase II study of the FSG-GETO
European Journal of Cancer · 2024
DOI: 10.1016/j.ejca.2024.114228 ↗Kurz gefasst
Klinische Studie (Phase II) in der Zeitschrift European Journal of Cancer, 2024. Verfasst von Jean-Yves Blay und 22 weiteren Autor:innen. Beteiligte Einrichtung: Centre Léon Bérard, CRCL, Unicancer, Lyon Unicancer & UCBL1, Lyon, France. Electronic address: jean-yves.blay@lyon.unicancer.fr. Hauptthemen laut MEDLINE: Osteosarcoma, Antineoplastic Combined Chemotherapy Protocols, Bone Neoplasms, Ifosfamide. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Network for Rare Adult Solid Cancers, LabEx DEvweCAN, INCa.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Centre Léon Bérard, CRCL, Unicancer, Lyon Unicancer & UCBL1, Lyon, France. Electronic address: jean-yves.blay@lyon.unicancer.fr.
- Centre Oscar Lambret, Lille, France.
- Institut Bergonié, Bordeaux, France.
- Institut Claudius Regaud, IUCT Oncopole, Toulouse, France.
- CHU, Besançon, France.
- Centre Alexis Vautrin, Nancy, France.
Förderung
- European Network for Rare Adult Solid Cancers
- LabEx DEvweCAN
- INCa
- Ligue Contre le Cancer
- European Commission
Zitieren
APA
Blay, J. Y., Penel, N., Toulmonde, M., Valentin, T., Chaigneau, L., Rios, M., Saada-Bouzid, E., Firmin, N., Bertucci, F., Marec-Berard, P., Ray-Coquard, I., Lervat, C., Rolland, F., Thyss, A., Conroy, T., Brahmi, M., Dufresne, A., Merrouche, Y., Brunat-Mentigny, M., …, & French Sarcoma Group (2024). Long term survival in adult osteosarcoma patients treated with a two-drug regimen: Final results of the OSAD93 phase II study of the FSG-GETO. European Journal of Cancer. https://doi.org/10.1016/j.ejca.2024.114228
Vancouver
Blay JY, Penel N, Toulmonde M, Valentin T, Chaigneau L, Rios M, et al. Long term survival in adult osteosarcoma patients treated with a two-drug regimen: Final results of the OSAD93 phase II study of the FSG-GETO. European Journal of Cancer. 2024. doi:10.1016/j.ejca.2024.114228
BibTeX
@article{Blay2024,
author = {Blay, Jean-Yves and Penel, Nicolas and Toulmonde, Maud and Valentin, Thibaud and Chaigneau, Loic and Rios, Maria and Saada-Bouzid, Esma and Firmin, Nelly and Bertucci, Francois and Marec-Berard, Perrine and Ray-Coquard, Isabelle and Lervat, Cyril and Rolland, Frederic and Thyss, Antoine and Conroy, Thierry and Brahmi, Mehdi and Dufresne, Armelle and Merrouche, Yacine and Brunat-Mentigny, Maud and Biron, Pierre and Bompas, Emmanuelle and Perol, David and French Sarcoma Group, French Sarcoma Group},
title = {Long term survival in adult osteosarcoma patients treated with a two-drug regimen: Final results of the OSAD93 phase II study of the FSG-GETO},
journal = {European Journal of Cancer},
year = {2024},
doi = {10.1016/j.ejca.2024.114228}
}
EUVIMED